Evidence map›Paper›PMID 35974795›Full record

ArticleBrain communications2022

Development of prognostic models for survival and care status in sporadic Creutzfeldt-Jakob disease.

Akın Nihat, Janice M Ranson, Dominique Harris, Kirsty McNiven, TzeHow Mok, Peter Rudge, John Collinge, David J Llewellyn, Simon Mead

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. FDG-PET patterns associate with survival in patients with prion disease.Annals of clinical and translational neurology · 2024
    Article
  4. Creutzfeldt-Jakob disease and other prion diseases.Nature reviews. Disease primers · 2024
    Review
  5. Article
  6. Article
  7. Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Akın NihatMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.ORCID https://orcid.org/0000-0003-2892-1402
Janice M RansonCollege of Medicine and Health, University of Exeter, Exeter EX1 2HZ, UK.
Dominique HarrisMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.
Kirsty McNivenNational Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.ORCID https://orcid.org/0000-0002-7525-2478
TzeHow MokMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.
Peter RudgeMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.
John CollingeMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.
David J LlewellynCollege of Medicine and Health, University of Exeter, Exeter EX1 2HZ, UK.
Simon MeadMRC Prion Unit at UCL, UCL Institute of Prion Diseases, Cleveland Street, London W1W 7FF, UK.
University College London Hospitals NHS Foundation Trust · GBMRC Prion Unit · GBTuring Institute · GBUniversity of Exeter · GB

Funding

Identifying modifiable aspects of gene-by-environment interplay in later-life cognitive declineRF1AG055654 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FAUL, JESSICA, GALAMA, TITUS JOHANNES · 2017 to 2018
$4.3M
Medical Research Council G0400713Medical Research Council MC_UU_00024/9NIA NIH HHS RF1 AG055654
6 · The paper itself

Abstract

Sporadic Creutzfeldt-Jakob disease, the most common human prion disease, typically presents as a rapidly progressive dementia and has a highly variable prognosis. Despite this heterogeneity, clinicians need to give timely advice on likely prognosis and care needs. No prognostic models have been developed that predict survival or time to increased care status from the point of diagnosis. We aimed to develop clinically useful prognostic models with data from a large prospective observational cohort study. Five hundred and thirty-seven patients were visited by mobile teams of doctors and nurses from the National Health Service National Prion Clinic within 5 days of notification of a suspected diagnosis of sporadic Creutzfeldt-Jakob disease, enrolled to the study between October 2008 and March 2020, and followed up until November 2020. Prediction of survival over 10-, 30- and 100-day periods was the main outcome. Escalation of care status over the same time periods was a secondary outcome for a subsample of 113 patients with low care status at initial assessment. Two hundred and eighty (52.1%) patients were female and the median age was 67.2 (interquartile range 10.5) years. Median survival from initial assessment was 24 days (range 0-1633); 414 patients died within 100 days (77%). Ten variables were included in the final prediction models: sex; days since symptom onset; baseline care status;

Indexed as

Creutzfeldt-Jakobdementiaprionprognosissurvival model

Identifiers

PMID35974795
PMCPMC9374480
OpenAlexW4289518315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.